All Stories

  1. Towards a subunit vaccine from a Shigella flexneri ΔtolR mutant

    Article • Vaccine, November 2018, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  2. Maternal Vaccination. Immunization of Sows during Pregnancy against ETEC Infections

    Article • Vaccines, December 2017, MDPI AG

    Professor Juan M. Irache, Professor Carlos Gamazo

  3. Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis

    Article • Immunotherapy, November 2017, Future Medicine

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  4. Adjuvants for allergy immunotherapeutics

    Article • Human Vaccines & Immunotherapeutics, August 2017, Taylor & Francis

    Dr Marta Ferrer, Professor Carlos Gamazo, Gabriel Gastaminza, Professor Juan M. Irache

  5. Chitosan/sulfated locust bean gum nanoparticles: In vitro and in vivo evaluation towards an application in oral immunization

    Article • International Journal of Biological Macromolecules, March 2017, Elsevier

    Professor Carlos Gamazo

  6. Topical immunization using a nanoemulsion containing bacterial membrane antigens

    Article • Journal of Drug Delivery Science and Technology, February 2017, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  7. Improved effect of amikacin-loaded Poly (D, L-lactide-co-glycolide) (PLGA) nanoparticles against Planktonic and biofilm cells of Pseudomonas aeruginosa

    Article • Journal of Medical Microbiology, January 2017, Society for General Microbiology

    Professor Juan M. Irache, Professor Carlos Gamazo

  8. Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia

    Article • Nanomedicine Nanotechnology Biology and Medicine, January 2017, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  9. New pharmaceutical approaches for the treatment of food allergies

    Article • Expert Opinion on Drug Delivery, October 2016, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  10. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa

    Article • European Journal of Pharmaceutical Sciences, October 2016, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  11. Interactions of poly (anhydride) nanoparticles with macrophages in light of their vaccine adjuvant properties

    Article • International Journal of Pharmaceutics, December 2015, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  12. Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2015, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  13. Nucleic acid vaccination strategies against infectious diseases

    Article • Expert Opinion on Drug Delivery, September 2015, Informa Healthcare

    Professor Carlos Gamazo

  14. Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock

    Article • Journal of Agricultural and Food Chemistry, June 2015, American Chemical Society (ACS)

    Professor Juan M. Irache, Professor Carlos Gamazo

  15. Nanoparticles as Adjuvants for Vaccination

    Article • September 2014, World Scientific Pub Co Pte Lt

    Professor Juan M. Irache, Professor Carlos Gamazo

  16. Development of a Bacterial Nanoparticle Vaccine

    Article • September 2014, Springer Science + Business Media

    Professor Juan M. Irache, Professor Carlos Gamazo

  17. Nanoparticle based-immunotherapy against allergy

    Article • Immunotherapy, July 2014, Future Medicine

    Dr Marta Ferrer, Professor Juan M. Irache, Professor Carlos Gamazo

  18. Immunogenicity of Peanut Proteins Containing Poly(Anhydride) Nanoparticles

    Article • Clinical and Vaccine Immunology, June 2014, ASM Journals

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  19. Vaccine Delivery Systems for Veterinary Immunization

    Article • January 2014, Springer Science + Business Media

    Professor Carlos Gamazo, Professor Juan M. Irache

  20. Antigen Delivery Systems as Oral Adjuvants

    Article • September 2013, Springer Science + Business Media

    Professor Carlos Gamazo, Professor Juan M. Irache

  21. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice

    Article • Vaccine, July 2013, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  22. Gentamicin-Loaded Nanoparticles Are Effective against Brucella melitensis

    Article • Antimicrobial Agents and Chemotherapy, May 2013, ASM Journals

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  23. Towards a non-living vaccine against Shigella flexneri: From the inactivation procedure to protection studies

    Article • Methods, May 2013, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  24. Radiomarcaje y estudios de biodistribución de nanopartículas poliméricas como adyuvantes para la vacunación oftálmica frente a la brucelosis

    Article • Revista Española de Medicina Nuclear e Imagen Molecular, March 2013, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  25. Recent progress towards development of aShigellavaccine

    Article • Expert Review of Vaccines, January 2013, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  26. Development of poly(anhydride) nanoparticles loaded with peanut proteins: The influence of preparation method on the immunogenic properties

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2012, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  27. Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles

    Article • Journal of Controlled Release, September 2012, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  28. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin

    Article • Journal of Antimicrobial Chemotherapy, May 2012, Oxford University Press (OUP)

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  29. Chapter 2.3. Nanostructures for Oral Vaccine Delivery

    Article • January 2012, Royal Society of Chemistry

    Professor Carlos Gamazo, Professor Juan M. Irache

  30. Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease

    Article • Expert Review of Vaccines, January 2012, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  31. Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy

    Article • Journal of Biomedicine and Biotechnology, January 2012, Hindawi Publishing Corporation

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  32. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice

    Article • Vaccine, October 2011, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  33. Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators

    Article • Vaccine, September 2011, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  34. Nanomedicine: Novel approaches in human and veterinary therapeutics

    Article • Veterinary Parasitology, August 2011, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  35. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections

    Article • Acta Biomaterialia, April 2011, Elsevier

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  36. Ara H 9 Is The Main Allergen In Peanut Allergic Patients In The Mediterranean Area Regardless The Symptom Severity

    Article • Journal of Allergy and Clinical Immunology, February 2011, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer

  37. High Loading of Gentamicin in Bioadhesive PVM/MA Nanostructured Microparticles Using Compressed Carbon-Dioxide

    Article • Pharmaceutical Research, December 2010, Springer Science + Business Media

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  38. Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation

    Article • Clinical and Vaccine Immunology, July 2010, ASM Journals

    Professor Carlos Gamazo, Professor Juan M. Irache

  39. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles

    Article • International Journal of Pharmaceutics, May 2010, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  40. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams

    Article • Vaccine, April 2010, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  41. Differences In The Immunologic Response To Peanut Allergen Depending Upon The Route, Lipid Content And Peanut Roasting In An Animal Model

    Article • Journal of Allergy and Clinical Immunology, February 2010, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer

  42. Drug delivery systems for potential treatment of intracellular bacterial infections

    Article • Frontiers in Bioscience, January 2010, Frontiers in Bioscience

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  43. Biofilm formation by Salmonella in food processing environments

    Article • October 2009, Taylor & Francis

    Professor Carlos Gamazo

  44. New adjuvants: from empiricism to science

    Article • Expert Review of Vaccines, October 2009, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  45. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne

    Article • Journal of Immunological Methods, August 2009, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  46. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination

    Article • Vaccine, July 2009, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  47. Design and influence of γ-irradiation on the biopharmaceutical properties of nanoparticles containing an antigenic complex from Brucella ovis

    Article • European Journal of Pharmaceutical Sciences, July 2009, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  48. Co-Delivery of Ovalbumin and CpG Motifs into Microparticles Protected Sensitized Mice from Anaphylaxis

    Article • International Archives of Allergy and Immunology, January 2009, Karger Publishers

    Professor Carlos Gamazo, Professor Juan M. Irache

  49. Biofilm formation by Salmonella in food processing environments

    Article • January 2009, Elsevier

    Professor Carlos Gamazo

  50. Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis

    Article • European Journal of Pharmaceutics and Biopharmaceutics, November 2008, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  51. Stability of Poly(ε-caprolactone) Microparticles Containing Brucella ovis Antigens as a Vaccine Delivery System Against Brucellosis

    Article • AAPS PharmSciTech, October 2008, American Association of Pharmaceutical Scientists (AAPS)

    Professor Carlos Gamazo, Professor Juan M. Irache

  52. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2008, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  53. Evaluation of Bioadhesive Capacity and Immunoadjuvant Properties of Vitamin B12-Gantrez Nanoparticles

    Article • Pharmaceutical Research, August 2008, Springer Science + Business Media

    Professor Carlos Gamazo, Professor Juan M. Irache

  54. Mannose-targeted systems for the delivery of therapeutics

    Article • Expert Opinion on Drug Delivery, June 2008, Informa Healthcare

    Professor Carlos Gamazo, Professor Juan M. Irache

  55. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles

    Article • Vaccine, November 2007, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  56. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections

    Article • Expert Opinion on Drug Delivery, October 2007, Informa Healthcare

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  57. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens

    Article • Vaccine, July 2007, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  58. Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice

    Article • Vaccine, May 2007, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  59. Nanoparticles as Adjuvant-Vectors for Vaccination

    Article • March 2007, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  60. Intradermal immunization with ovalbumin-loaded poly-?-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice

    Article • Clinical & Experimental Allergy, February 2007, Wiley

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  61. Gamma Interferon Loaded onto Albumin Nanoparticles: In Vitro and In Vivo Activities against Brucella abortus

    Article • Antimicrobial Agents and Chemotherapy, January 2007, ASM Journals

    Professor Carlos Gamazo, Professor Juan M. Irache

  62. Poly(d,l-Lactide-Coglycolide) Particles Containing Gentamicin: Pharmacokinetics and Pharmacodynamics in Brucella melitensis- Infected Mice

    Article • Antimicrobial Agents and Chemotherapy, January 2007, ASM Journals

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  63. Encapsulation of antigenic extracts of Salmonella enterica serovar

    Article • Veterinary Microbiology, November 2006, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  64. Chemical and Biological Factors in the Control of Brucella and Brucellosis

    Article • Current Drug Delivery, October 2006, Bentham Science Publishers

    Professor Carlos Gamazo, Professor Juan M. Irache, Professor Maria J Blanco-Prieto

  65. Bioadhesive Mannosylated Nanoparticles for Oral Drug Delivery

    Article • Journal of Nanoscience and Nanotechnology, September 2006, American Scientific Publishers

    Professor Carlos Gamazo, Professor Juan M. Irache

  66. Development of a Novel Vaccine Delivery System Based on Gantrez Nanoparticles

    Article • Journal of Nanoscience and Nanotechnology, September 2006, American Scientific Publishers

    Professor Carlos Gamazo, Dr Marta Ferrer, Professor Juan M. Irache

  67. Nanocarriers with Gentamicin to Treat Intracellular Pathogens

    Article • Journal of Nanoscience and Nanotechnology, September 2006, American Scientific Publishers

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  68. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin

    Article • Journal of Antimicrobial Chemotherapy, July 2006, Oxford University Press (OUP)

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  69. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method

    Article • Journal of Antimicrobial Chemotherapy, June 2006, Oxford University Press (OUP)

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  70. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice

    Article • Vaccine, May 2006, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  71. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams

    Article • Vaccine, March 2006, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  72. Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery

    Article • Journal of Microencapsulation, January 2006, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  73. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin

    Article • Journal of Microencapsulation, January 2006, Taylor & Francis

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  74. BapA, a large secreted protein required for biofilm formation and host colonization of Salmonella enterica serovar Enteritidis

    Article • Molecular Microbiology, October 2005, Wiley

    Professor Carlos Gamazo

  75. Salmonella-like bioadhesive nanoparticles

    Article • Journal of Controlled Release, August 2005, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  76. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice

    Article • Journal of Antimicrobial Chemotherapy, April 2005, Oxford University Press (OUP)

    Professor Juan M. Irache, Professor Carlos Gamazo

  77. Bioadhesive properties of pegylated nanoparticles

    Article • Expert Opinion on Drug Delivery, March 2005, Informa Healthcare

    Professor Carlos Gamazo, Professor Juan M. Irache

  78. Protective ability of subcellular extracts from Salmonella Enteritidis and from a rough isogenic mutant against salmonellosis in mice

    Article • Vaccine, February 2005, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  79. Gantrez® AN nanoparticles do not alter allergenicity of Lollium extract

    Article • Journal of Allergy and Clinical Immunology, February 2005, Elsevier

    Professor Carlos Gamazo, Dr Marta Ferrer

  80. Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation

    Article • Molecular Microbiology, August 2004, Wiley

    Professor Carlos Gamazo

  81. Humoral immune response in hens naturally infected withSalmonellaEnteritidis against outer membrane proteins and other surface structural antigens

    Article • Veterinary Research, May 2004, EDP Sciences

    Professor Carlos Gamazo, Professor Juan M. Irache

  82. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes

    Article • Journal of Antimicrobial Chemotherapy, April 2004, Oxford University Press (OUP)

    Professor Juan M. Irache, Professor Carlos Gamazo

  83. New Therapeutic Approaches for the Treatment of Brucella Infections: Gentamicin Entrapment into Drug Delivery Systems

    Article • Current Medicinal Chemistry - Anti-Infective Agents, March 2004, Bentham Science Publishers

    Professor Carlos Gamazo, Professor Juan M. Irache

  84. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis

    Article • International Journal of Pharmaceutics, March 2004, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  85. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice

    Article • Journal of Antimicrobial Chemotherapy, August 2003, Oxford University Press (OUP)

    Professor Juan M. Irache, Professor Carlos Gamazo

  86. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens

    Article • Journal of Controlled Release, December 2002, Elsevier

    Professor Juan M. Irache, Professor Carlos Gamazo

  87. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis

    Article • International Journal of Pharmaceutics, August 2002, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache, Professor Maria J Blanco-Prieto

  88. In vitro evaluation of gentamicin released from microparticles

    Article • International Journal of Pharmaceutics, August 2002, Elsevier

    Professor Carlos Gamazo, Professor Maria J Blanco-Prieto

  89. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres

    Article • European Journal of Pharmaceutical Sciences, March 2002, Elsevier

    Professor Carlos Gamazo, Professor Hans P Merkle, Professor Juan M. Irache

  90. Genetic analysis ofSalmonella enteritidisbiofilm formation: critical role of cellulose

    Article • Molecular Microbiology, February 2002, Wiley

    Professor Carlos Gamazo

  91. Polyester Microparticles as a Vaccine Delivery System for Brucellosis: Influence of the Polymer on Release, Phagocytosis and Toxicity

    Article • Journal of Drug Targeting, January 2002, Taylor & Francis

    Professor Carlos Gamazo, Professor Juan M. Irache

  92. Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies

    Article • Journal of Medical Microbiology, November 2001, Society for General Microbiology

    Professor Carlos Gamazo

  93. A Brucella ovis antigenic complex bearing poly-ε-caprolactone microparticles confer protection against experimental brucellosis in mice

    Article • Vaccine, July 2001, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  94. Virulent strains of Salmonella enteritidis disrupt the epithelial barrier of Caco-2 and HEp-2 cells

    Article • Archives of Microbiology, January 2001, Springer Science + Business Media

    Professor Carlos Gamazo

  95. The relationship between glycogen synthesis, biofilm formation and virulence in Salmonella enteritidis

    Article • FEMS Microbiology Letters, October 2000, Oxford University Press (OUP)

    Professor Carlos Gamazo

  96. The relationship between glycogen synthesis, biofilm formation and virulence in Salmonella enteritidis

    Article • FEMS Microbiology Letters, October 2000, Oxford University Press (OUP)

    Professor Carlos Gamazo

  97. Enzyme-linked immunosorbent assay with a Salmonella enteritidis antigen for differentiating infected from vaccinated poultry

    Article • Veterinary Research, September 2000, EDP Sciences

    Professor Carlos Gamazo

  98. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections

    Article • International Journal of Pharmaceutics, February 2000, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  99. Anti-Phosphatidylcholine Antibodies in Patients with Brucellosis

    Article • Journal of Medical Microbiology, January 1998, Society for General Microbiology

    Professor Carlos Gamazo

  100. Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity

    Article • International Journal of Pharmaceutics, December 1997, Elsevier

    Professor Carlos Gamazo, Professor Juan M. Irache

  101. Protective Effect of Liposomal Gentamicin against Systemic Acute Murine Brucellosis

    Article • Chemotherapy, January 1997, Karger Publishers

    Professor Carlos Gamazo

  102. Inadequate Azithromycin Activity againstBrucella melitensisin Mice with Acute or Chronic Infections

    Article • Journal of Chemotherapy, January 1996, Taylor & Francis

    Professor Carlos Gamazo

  103. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice

    Article • FEMS Immunology & Medical Microbiology, October 1995, Oxford University Press (OUP)

    Professor Carlos Gamazo

  104. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice

    Article • FEMS Immunology & Medical Microbiology, October 1995, Wiley

    Professor Carlos Gamazo

  105. Protective effect of Brucella outer membrane complex-bearing liposomes against experimental murine brucellosis

    Article • FEMS Microbiology Letters, August 1995, Oxford University Press (OUP)

    Professor Carlos Gamazo

  106. Protective effect of Brucella outer membrane complex-bearing liposomes against experimental murine brucellosis

    Article • FEMS Microbiology Letters, August 1995, Oxford University Press (OUP)

    Professor Carlos Gamazo

  107. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice

    Article • Journal of Antimicrobial Chemotherapy, January 1995, Oxford University Press (OUP)

    Professor Carlos Gamazo

  108. Brucella group 3 outer membrane proteins contain a heat-modifiable protein

    Article • FEMS Microbiology Letters, September 1993, Oxford University Press (OUP)

    Professor Carlos Gamazo

  109. Brucella group 3 outer membrane proteins contain a heat-modifiable protein

    Article • FEMS Microbiology Letters, September 1993, Oxford University Press (OUP)

    Professor Carlos Gamazo

  110. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams

    Article • Veterinary Immunology and Immunopathology, August 1993, Elsevier

    Professor Ignacio Moriyon, Professor Carlos Gamazo

  111. An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination

    Article • Veterinary Microbiology, February 1992, Elsevier

    Professor Ignacio Moriyon, Professor Carlos Gamazo

  112. Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts

    Article • Veterinary Record, November 1989, BMJ

    Professor Ignacio Moriyon, Professor Carlos Gamazo

  113. Properties of the outer membrane of Brucella

    Article • Annales de l Institut Pasteur Microbiologie, January 1987, Elsevier

    Professor Ignacio Moriyon, Professor Carlos Gamazo

  114. NANOPARTICLES FOR ORAL VACCINATION

    Article • World Scientific Pub Co Pte Lt

    Professor Carlos Gamazo, Professor Juan M. Irache